420 related articles for article (PubMed ID: 33567957)
21. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.
Pan B; Yang M; Wei X; Li W; Wang K; Yang M; Lu D; Wang R; Cen B; Xu X
Aging (Albany NY); 2021 Jul; 13(14):18620-18644. PubMed ID: 34282055
[TBL] [Abstract][Full Text] [Related]
23. Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells.
Peng J; Li C; Zhou J; Peng J; Wang C; Lai S; Guo S; Zhong Y; Deng L; Tang X
Gene; 2020 Nov; 761():145028. PubMed ID: 32763490
[TBL] [Abstract][Full Text] [Related]
24. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
Shi Y; Wang Y; Yang R; Zhang W; Zhang Y; Feng K; Lv Q; Niu K; Chen J; Li L; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1090324. PubMed ID: 36605944
[TBL] [Abstract][Full Text] [Related]
25. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L
Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
[TBL] [Abstract][Full Text] [Related]
27. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
28. Potential biomarkers for the prognosis and treatment of HCC immunotherapy.
Li H; He Q; Zhou GM; Wang WJ; Shi PP; Wang ZH
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2027-2046. PubMed ID: 36930502
[TBL] [Abstract][Full Text] [Related]
29. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
30. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
[TBL] [Abstract][Full Text] [Related]
31. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
32. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma.
Huang N; Zhang J; Kuang S; Li Z; Zhao H; Wu J; Liu M; Wang L
Cancer Med; 2023 Apr; 12(7):8991-9004. PubMed ID: 36680322
[TBL] [Abstract][Full Text] [Related]
33. Molecular characteristics of novel immune subtypes of HCC based on lncRNAs related to immune disorders.
Zhang Q; Yu X; Zhang S; Guo W; He Y
Sci Rep; 2022 May; 12(1):8905. PubMed ID: 35618810
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma.
Yin T; Zhao L; Yao S
BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168
[TBL] [Abstract][Full Text] [Related]
35. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
[TBL] [Abstract][Full Text] [Related]
37. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
38. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma.
Wang Z; Chen X; Zhang J; Chen X; Peng J; Huang W
Front Immunol; 2023; 14():1204338. PubMed ID: 37680641
[TBL] [Abstract][Full Text] [Related]
39. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
40. An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis.
Xie J; Chen L; Sun Q; Li H; Wei W; Wu D; Hu Y; Zhu Z; Shi J; Wang M
Aging (Albany NY); 2022 Apr; 14(7):3276-3292. PubMed ID: 35413690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
